Copay Accumulators: Are Your Patients Really at Risk?
Two experts in health economics and patient support team up to offer insight on how manufacturers can prepare for the impact of copay accumulators.
Managing the Growing Expansion of Copay Accumulators
Moving Medicare Coverage
Executive Q&A: How shifting coverage for some drugs from Medicare Part B to Part D could impact access and affordability for patients.
The Power of Patient Activation: eBook
What are the pitfalls of historic approaches to adherence? Learn how leading solutions combine both measurement and engagement for real results.
Preparing Patients for Open Enrollment
Open enrollment for Health Insurance Marketplace plans is here. Do PAP patients know their coverage options?
The Power of Patient Activation: Part Two
How leading patient support providers combine measurement with engagement to improve adherence.
The Power of Patient Activation: Part One
The evolving needs of the patient and historic approaches to non-adherence.
The Economics Behind Patient Access
Executive Q&A: how pharmaceutical distributors are compensated and the value they deliver to the healthcare supply chain.
How Policy Impacts Patient Support
What role does the changing healthcare coverage landscape play in support program demand and design?
How New Contracting Models Challenge Efficiency and Value
Our strategic global sourcing experts explain how proposed new contracting models impact efficiency, and why they may not be ideal for the industry at large.
Understanding and Addressing Critical Barriers
Patients face a growing number of barriers that can impede medication access and adherence. How can manufacturers help address these hurdles?
The Value-Added Services of Specialty Pharmacy
Learn how the right specialty pharmacy can offer value-added services for physician practices and patients.
A New Approach to Channel Strategy for Oncology Therapies
How is manufacturer thinking around channel strategy changing for oral oncolytics?
Payer Perspectives on the Cost of Copay Programs
Xcenda examines payer tactics for managing commercial copay assistance in a new issue brief.
Patient Support Programs: One Size Does Not Fit All
How medication adherence strategies are evolving to meet each individual’s unique needs.
Rethinking Reimbursement and Patient Support Following Medical Innovation
How can manufacturers approach reimbursement and patient support for cell and gene therapies and other medical innovations?
Affordability and Access Will Drive Biosimilar Success
U.S. biosimilars are coming, just as they’ve arrived and prospered in the Europe. By ensuring positive patient experiences, specialty pharmacies will help usher in a sustainable wave of biosimilar products.
Rethink: The Future of Benefit Verification
What does the future of benefit verification look like for manufacturer patient support programs?
Add Value to Your Specialty Strategy
What should manufacturers look for in a specialty pharmacy partner? Learn six ways the right SP can add value.
Commercializing Cell and Gene Therapies
Learn what it takes to design an effective commercialization strategy and execute an integrated solution when the patient is in the supply chain.
Designing Patient-centric Support Programs
Explore what it means to put patients at the center of support program design through this interactive experience drawing perspective from real patients and how they view healthcare.
Orphan Drugs: Five Ways to Prove Product Value
Demonstrate the value of rare disease therapies with these five key ways to connect where patients, physicians and payers perceive the most value.
Cancer Care at a Crossroads
A look at the trends and growth of cancer care alongside the critical considerations health systems need to weigh as they look to deliver the highest quality.
Patient-Centric Product Commercialization: Part Three
Designing support programs that are truly patient-centric and overcoming obstacles along the way.
Patient-Centric Product Commercialization: Part Two
Mapping the patient journey and building support programs that address the three biggest hurdles patients face.
The Future of Patient Assistance Programs in Canada
As global manufacturers of specialty pharmaceuticals look to enter the Canadian market, it is important to understand the Canadian healthcare landscape with the provision of patient support services being an important consideration.